Skip to content

Osteopathic Manual Therapy vs Ganglion Impar Block for Chronic Coccydynia

Comparison of Osteopathic Manual Therapy and Ganglion Impar Block in Patients With Chronic Coccydynia

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07426497
Acronym
COCCY-OMT-GIB
Enrollment
100
Registered
2026-02-23
Start date
2025-08-28
Completion date
2026-02-16
Last updated
2026-02-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Coccydynia, Chronic Pain, Coccygodynia

Keywords

Chronic coccydynia, Ganglion impar block, Osteopathic manual therapy, Coccyx pain, Manual therapy, Interventional pain, Numeric Rating Scale

Brief summary

Chronic coccydynia is a condition characterized by persistent pain in the coccyx region that can significantly impair sitting tolerance, daily activities, and quality of life. Various conservative and interventional treatment options have been described, including manual therapy techniques and ganglion impar block. However, the comparative effectiveness of these approaches remains unclear. The aim of this randomized controlled study is to compare the effects of osteopathic manual therapy and ganglion impar block on pain intensity and functional disability in patients with chronic coccydynia. Participants will be randomly assigned to one of the two treatment groups. Pain severity will be assessed using the Numeric Rating Scale (NRS), and functional status will be evaluated with the Oswestry Disability Index (ODI) at baseline, week 3, and month 3. The results of this study are expected to provide evidence regarding the relative effectiveness of these two commonly used treatment methods and to guide clinicians in selecting appropriate management strategies for patients with chronic coccydynia.

Detailed description

Chronic coccydynia is a multifactorial pain syndrome affecting the coccygeal region and is often associated with trauma, prolonged sitting, obesity, or idiopathic causes. Patients frequently report severe localized pain that worsens with sitting and transitions from sitting to standing. Conservative treatment options include physical therapy modalities and manual therapy techniques, while interventional procedures such as ganglion impar block are commonly used in refractory cases. This prospective randomized controlled trial aims to compare the clinical effectiveness of osteopathic manual therapy and ganglion impar block in patients with chronic coccydynia. Eligible patients will be randomly allocated into two groups. The osteopathic manual therapy group will receive standardized manual therapy sessions targeting pelvic alignment, sacrococcygeal mobility, and surrounding soft tissue structures. The ganglion impar block group will undergo fluoroscopy-guided ganglion impar injection performed under sterile conditions. Primary outcome measures will include pain intensity assessed by the Numeric Rating Scale (NRS). Secondary outcomes will include functional disability assessed by the Oswestry Disability Index (ODI). Assessments will be performed at baseline, week 3, and month 3 follow-up. The study is conducted at Medicana Zincirlikuyu Hospital in collaboration with Istanbul Atlas University. Ethical approval has been obtained from the Istanbul Atlas University Clinical Research Ethics Committee. The findings of this trial will contribute to the evidence base regarding non-surgical management options for chronic coccydynia.

Interventions

Osteopathic manual therapy was applied to the sacrococcygeal region. Techniques included myofascial release, ligamentous tension balancing, and gentle mobilization. Treatment was performed once weekly for three consecutive weeks by a certified practitioner.

A single ganglion impar block was performed under fluoroscopic guidance using local anesthetic combined with corticosteroid. The procedure was carried out under sterile conditions without additional manual therapy.

Sponsors

Istanbul Medeniyet University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 75 Years
Healthy volunteers
No

Inclusion criteria

* Age 18-75 years * Chronic coccygodynia ≥3 months * Baseline NRS ≥4 * ODI ≥20 * Failure of prior conservative treatment * Imaging excludes fracture, infection, or malignancy * Ability to provide written informed consent

Exclusion criteria

* Acute coccygodynia * Prior spinal or coccygeal surgery * Malignancy * Pelvic fracture * Pregnancy * Coagulation disorder * Severe psychiatric disease * Prior osteopathic manual therapy or ganglion impar block

Design outcomes

Primary

MeasureTime frameDescription
Oswestry Disability Index (ODI) change from baselineBaseline and 3 monthsChange in functional disability measured by the Oswestry Disability Index (ODI, 0-100; 0 = no disability, 100 = maximum disability; higher scores indicate worse disability). Mean change from baseline to 3 months will be compared between groups.

Secondary

MeasureTime frameDescription
Numeric Rating Scale (NRS) pain change at 3 weeksBaseline and 3 weeksChange in pain intensity measured by the Numeric Rating Scale (NRS, 0-10; 0 = no pain, 10 = worst imaginable pain; higher scores indicate worse pain). Mean change from baseline to 3 weeks will be compared between groups.
Numeric Rating Scale (NRS) pain change at 3 monthsBaseline and 3 monthsChange in pain intensity measured by the Numeric Rating Scale (NRS, 0-10; higher scores indicate worse pain). Mean change from baseline to 3 months will be compared between groups.
Oswestry Disability Index (ODI) change at 3 weeksBaseline and 3 weeksChange in functional disability measured by the Oswestry Disability Index (ODI, 0-100; higher scores indicate worse disability). Mean change from baseline to 3 weeks will be compared between groups.
Patient Global Impression of Change (PGIC) score3 weeks and 3 monthsPatient Global Impression of Change (PGIC; 7-point scale from 1 = very much improved to 7 = very much worse; lower scores indicate better outcome). Mean PGIC score will be compared between groups.

Countries

Turkey (Türkiye)

Contacts

CONTACTmert sancar, MD
mrtsncr88@gmail.com5076367611
CONTACTEkim Can Ozturk, Md
ekimtrilogy@gmail.com5448294239

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 25, 2026